My monthly blood test results show that my cancer levels (m protein) jumped from 25 to between 31 and 32. This is after they spiked from 20 to 25 in June. My Myeloma Specialist/Hematologist and I also use a general measure, called an igG, to get a more complete picture of my progress. My igG also increased from 30.5 to 40.4. Unfortunately these cancer levels are pretty high.
Right now, we need to get my cancer levels lower. I’ve always responded well to Dexamethasone (steroid). When my new 4 week treatment cycle begins on Monday, I will be on Dexamethasone again with my Ninlaro + Pomalyst chemo. For the first cycle (July 23th), my dosage will be 40mg and for the next cycle (Aug 20th), it will be 20mg.
This isn’t the greatest news, but I’m focused on staying positive and optimistic.
Have a great day!
M protein (g/L) (0 = no cancer detected)
July = between 31 and 32
June = 25
May = 20
Apr = 20
Mar = 13
Feb = value missing (believe similar to January)
Jan 2018 = 13 (began Ninlaro chemo – Jan 8th)
Dec = between 10 and 11
Nov = 8
Late Oct = 9
Early Oct = between 5 and 6
Sept = under 7.7
Aug 2017 = value missing
Feb 2015 (began Pomalyst chemo + dexamethasone) = 36.1
igG protein (6.7 – 15.2 normal levels)
July = 40.4
June = 30.5
May = 25.8
Apr = 22.7
Mar = 22.0
Feb = 23.1
Jan 2018 = 20.6
On Sunday, July 15th, I completed Cycle 45 Week 3. I have multiple myeloma and anemia, a rare cancer of the immune system. Multiple myeloma affects the plasma cells, a type of immune cell that produces antibodies to fight infection. These plasma cells are found in the bone marrow. As a blood cancer, it is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and Dexamethasone chemo treatment (Pom/Dex). On July 16th 2017, my Dexamethasone treatment ended, due to right eye damage, reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo to combat steadily rising cancer levels.
Weekly chemo-inspired self-portraits can be viewed in my flickr album.